Project/Area Number |
23500429
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Nerve anatomy/Neuropathology
|
Research Institution | Kyushu University |
Principal Investigator |
SATOSHI Suzuki 九州大学, 医学(系)研究科(研究院), 准教授 (90294917)
|
Co-Investigator(Renkei-kenkyūsha) |
IWAKI Toru 九州大学, 大学院・医学研究院神経病理学 (40221098)
|
Project Period (FY) |
2011 – 2013
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | 脳腫瘍 / グリオーマ / イソクエン酸脱水素酵素1 / 免疫組織化学 / glioma / astrocytoma / oligodendroglioma / glioblastoma / IDH1 / immunohistochemistry |
Research Abstract |
To evaluate heterogeneity among cells in glioma tissues, we performed immunohistochemistry against mutant isocitrate dehydrogenase 1, a marker for a representative gene alteration in gliomas, together with other glioma markers (MAP-2e, p53, DCX, nestin), a proliferation marker (Ki-67) and lineage-specific markers (GFAP, Olig2, Iba-1). The results suggest existence of different tumor cell components with different genetic backgrounds and/or reactive components with a similar biological behavior to tumor cells even in one same tumor tissue. The findings would lead to the identification of tumor initiating cells, potentially a genuine therapeutic target, in tissue sections.
|